2023

1. Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

   Annals of Hematology, Vol. 102, Núm. 2, pp. 429-437

2. Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain

   European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490